CVE-2022-40744 IBM Aspera Faspex cross-site scripting

What is CVE-2022-40744?

CVE-2022-40744 is a medium-severity cross-site scripting vulnerability in IBM Aspera Faspex, published on 2 Feb 2024. An attacker needs administrator access to exploit it, and only if a user opens a file or follows a link.

Official description

IBM Aspera Faspex 5.0.6 is vulnerable to stored cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session. IBM X-Force ID: 236441.

Weakness: CWE-79

Which versions are affected by CVE-2022-40744?

It affects 1 product.

Products include Ibm Aspera Faspex.

How do I fix CVE-2022-40744?

No fix has been published for CVE-2022-40744 yet. Limit exposure of the affected software until one is available.

Escape output for the context it lands in and set a strict Content Security Policy. Upgrading the affected component is the real fix. More about Cross-site scripting.

Is CVE-2022-40744 being exploited?

There is no known exploitation of CVE-2022-40744 in the wild and no public exploit code.

Other vulnerabilities in IBM Aspera Faspex

• CVE-2022-47986 IBM Aspera Faspex Code Execution Exploited Critical 9.8
• CVE-2023-27874 IBM Aspera Faspex XML external entity injection Critical 9.9
• CVE-2026-14958 OS command injection in IBM Aspera Faspex Critical 9.1
• CVE-2026-14959 OS Command Injection in IBM Aspera Faspex Critical 9.1
• CVE-2026-14996 Multiple vulnerabilities in IBM Aspera Faspex High 8.2

Sources

• CVE record
• NVD
• OSV
• GitHub advisory
• How this page is made

Also known as GHSA-97fg-5ggq-j35p.